| EPSRC Reference: |
EP/F013655/1 |
| Title: |
DEVELOPING COLLABORATIVE STRATEGIES TO GUIDE FUTURE DIRECTIONS IN MICROBUBBLE ENHANCED THERAPEUTIC ULTRASOUND |
| Principal Investigator: |
Campbell, Dr PA |
| Other Investigators: |
|
| Researcher Co-Investigators: |
|
| Project Partners: |
|
| Department: |
Electronic Engineering and Physics |
| Organisation: |
University of Dundee |
| Scheme: |
Standard Research |
| Starts: |
01 October 2007 |
Ends: |
30 June 2008 |
Value (£): |
51,648
|
| EPSRC Research Topic Classifications: |
| Drug Formulation & Delivery |
Medical science & disease |
|
| EPSRC Industrial Sector Classifications: |
| Healthcare |
Pharmaceuticals and Biotechnology |
|
| Related Grants: |
|
| Panel History: |
| Panel Date | Panel Name | Outcome |
|
30 Apr 2007
|
Collaborating for Success Through People
|
Announced
|
|
|
Summary on Grant Application Form |
|
Modern medical ultrasonics may be viewed as having evolved through three generations of applications. The first generation emphasizes diagnostic imaging, employing relatively passive ultrasound fields. The second generation has deliberately exploited more aggressive ultrasound regimes for direct interventional approaches, including lithotripsy (of ductal calculi), phacoemulsification (of cataracts), and HIFU for tumour ablation, thrombolysis, and haemostatis.A third and emerging area involves an indirect therapeutic application of ultrasound to actively sensitize tissue, or otherwise enhance the efficacy for parallel administration of biotherapeutics. Here, particular progress has been achieved with ultrasound assisted transdermal delivery. However, this has been facilitated, in part, because the target tissue (i.e., stratum corneum) is non-viable. Perhaps the most challenging avenue for therapeutic ultrasound is to facilitate molecular delivery whilst retaining tissue viability, the criteria necessary for drug- and gene-based therapies. Excitingly, initial in vitro demonstrations of enhanced transfection and also increased sensitivity to chemotherapeutic agents, have now also been realized with compelling in-vivo validations. Evidently, this latter category of ultrasound-mediated therapy holds promise for a diversity of potential uses. However, reducing the multiplicity of these abstract possibilities to the more refined base of concrete realizations that are best suited to ultrasonic enhancement requires strategic action. Targeting research with the greatest impact requires an understanding of the strengths and weaknesses of ultrasound's bioeffects, which remain poorly understood at a mechanistic level. This situation hinders insight and indeed foresight into the future of this field. THis latter paragraph embraces the spirit of the present proposal. It is proposed to interact with several new UK and international partners in order to meet the needs of the next generation of sonoporation trials that will assist translation of this technique towards the clinic. The critical questions to be answered include:Are the primary effects of ultrasound itself responsible for bioeffects, or are secondary effects involving shock waves, fluid shearing, and sonochemistry involved? If so, what is the relative importance of each in dictating overall bioeffect? Which forms of ultrasonic effects are responsible for increased sensitivity to gene transfection, to cancer therapy, to intracellular drug delivery? Can ultrasonic effects that are effective in vitro be reproduced in vivo, where perfusion of cavitation nucleation sites (e.g., contrast agent microbubbles) and stimulation of bubble activity in the dense environment of a solid tissue may be difficult? Can isolated cell and single-bubble experiments in vitro predict behaviour of multicellular tissue exposure to bubble clouds found in vivo? Finally, which physical properties should micro-bubbles exhibit in order to target specific therapies, and how should ultrasound transducers be designed to control and optimize cavitational and other activity within the body?
|
|
Key Findings |
|
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
|
|
Potential use in non-academic contexts |
|
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
|
|
Impacts |
|
| Description |
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk |
| Summary |
|
| Date Materialised |
|
|
|
|
Sectors submitted by the Researcher |
|
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
|
| Project URL: |
|
| Further Information: |
|
| Organisation Website: |
http://www.dundee.ac.uk |